CIK 0001599298
- Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 371979717
- Phone
- +1 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- SC 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
Page 1 of 3 · 45 filings